You are here

Article Text

Article menu
Download PDFPDF
Editorial
Results of the early stage PD MED study: revelation or recapitulation?

https://doi.org/10.1136/practneurol-2015-001149

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Correction notice This paper has been amended since it was published Online First. The second paragraph has been rewritten. Also on the first page, top of the second column the author cites a study published by The Lancet about the results of the long-awaited early stage PD MED study. The reference to this study has been added to the reference list.

    • Competing interests PW has received honoraria and consulting fees from Medtronic, Boehringer-Ingelheim, UCB Pharma, Brittania, Abbvie, Teva and Lundbeck.

    • Provenance and peer review Commissioned; externally peer reviewed. This paper was reviewed by Simon Lewis, Sydney, Australia.

    Other content recommended for you